Valsartan and Hydrochlorothiazide
- Product NDC
- 70934-265
- 11-digit product format
- 709340265
- Labeler code
- 70934
- Product ID
- 70934-265_b7b470cd-fc52-5fdf-e053-2a95a90aad2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA203145
- Marketing category
- ANDA
- Marketing start
- 2019-02-07
- Marketing end
- 0000-00-00
- Substance
- VALSARTAN; HYDROCHLOROTHIAZIDE
- Active strength
- 160 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-265-30 | 70934026530 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-265-30) | 2019-02-07 | 0000-00-00 | No | No | Current |